955306105 13F position history: Bill & Melinda Gates Foundation Trust
WEST PHARMACEUTICAL SVSC INC, as reported in Bill & Melinda Gates Foundation Trust’s quarterly 13F filings.
| Quarter | Activity | Shares | Value | % of portfolio | Reported price | |
|---|---|---|---|---|---|---|
| Q2 2026 | No change | 444,500 | $159,575,500 | 0.46% | $359.00 | Filing |
| Q1 2026 | No change | 444,500 | $111,409,480 | 0.35% | $250.64 | Filing |
| Q4 2025 | No change | 444,500 | $122,299,730 | 0.35% | $275.14 | Filing |
| Q3 2025 | No change | 444,500 | $116,605,685 | 0.32% | $262.33 | Filing |
| Q2 2025 | No change | 444,500 | $97,256,600 | 0.20% | $218.80 | Filing |
| Q1 2025 | New | 444,500 | $99,514,660 | 0.24% | $223.88 | Filing |